Acute coronary syndrome: biochemical strategies in the troponin era.

New biomarkers, such as cardiac troponins, have a major role to play for cost-effective management of individuals with acute chest pain and suspected coronary syndrome, and the laboratory is now poised to assume a vital role in assessing damage and determining prognosis. The redefined biochemical criterion proposed to classify acute coronary syndrome patients presenting with ischemic symptoms as patients with myocardial infarction is heavily predicated on an increased troponin concentration in blood. In an era of evidence-based medicine, we can no longer overlook the diagnostic and prognostic benefits provided by the measurement of these highly sensitive and specific proteins.

[1]  A. Wu,et al.  Quality Specifications for Cardiac Troponin Assays , 2001, Clinical chemistry and laboratory medicine.

[2]  A. Wu,et al.  Myocardial infarction redefined: role of cardiac troponin testing. , 2001, Clinical chemistry.

[3]  A. Owen,et al.  Troponin T: role in altering patient management and enabling earlier discharge from a district general hospital , 2001, Annals of clinical biochemistry.

[4]  A. Wu,et al.  International survey on the use of cardiac markers. , 2001, Clinical chemistry.

[5]  J. Kao,et al.  Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitros ECi for measurement of cardiac troponin I , 2001, Annals of clinical biochemistry.

[6]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[7]  M. Panteghini Recent approaches to the standardization of cardiac markers , 2001, Scandinavian journal of clinical and laboratory investigation.

[8]  H. Katus,et al.  Risk Stratification in Patients With Inferior Acute Myocardial Infarction Treated by Percutaneous Coronary Interventions: The Role of Admission Troponin T , 2000, Circulation.

[9]  A. Siegbahn,et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.

[10]  S. Kaul,et al.  Elevated Troponin I Level on Admission Is Associated With Adverse Outcome of Primary Angioplasty in Acute Myocardial Infarction , 2000, Circulation.

[11]  S. Kahn The challenge of evaluating the patient with chest pain. , 2000, Archives of pathology & laboratory medicine.

[12]  P. Collinson,et al.  Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. , 2000, Clinical chemistry.

[13]  T. Caragher,et al.  Long-term experience with an accelerated protocol for diagnosis of chest pain. , 2000, Archives of pathology & laboratory medicine.

[14]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[15]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[16]  U. Janssens,et al.  Lower cardiac troponin T and I results in heparin-plasma than in serum. , 2000, Clinical chemistry.

[17]  M. Plebani,et al.  Rapid measurement of cardiac markers on Stratus CS. , 2000, Clinical chemistry.

[18]  J P Ornato,et al.  Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. , 2000, JAMA.

[19]  S. Blankenberg,et al.  Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM , 2000, Clinical chemistry and laboratory medicine.

[20]  Robert Woolard,et al.  Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department , 2000 .

[21]  L. Goldman,et al.  Evaluation of the patient with acute chest pain. , 2000, The New England journal of medicine.

[22]  E. Antman,et al.  Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. , 2000, Clinical chemistry.

[23]  J. Ravkilde Risk stratification in acute coronary syndrome using cardiac troponin I. , 2000, Clinical chemistry.

[24]  F. Apple,et al.  Preliminary evaluation of the Vitros ECi cardiac troponin I assay. , 2000, Clinical chemistry.

[25]  M. Panteghini Present issues in the determination of troponins and other markers of cardiac damage. , 2000, Clinical biochemistry.

[26]  R. Jesse,et al.  Evaluation of the emergency department chest pain patient. , 2000, The American journal of cardiology.

[27]  M. Panteghini,et al.  Determination of Decision Limits for ACS:Systems Cardiac Troponin I , 2000, Clinical chemistry and laboratory medicine.

[28]  R. Califf,et al.  Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. , 1999, The American journal of cardiology.

[29]  I. Menown,et al.  Optimizing classification of acute myocardial infarction: from diagnosis to prognosis. , 1999, European heart journal.

[30]  J. Soler‐Soler,et al.  QT dispersion after myocardial infarction with heart failure: additional prognostic marker? , 1999, European heart journal.

[31]  A. Remppis,et al.  Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing. , 1999, Clinical chemistry.

[32]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[33]  A. Jaffe,et al.  2001--a biomarker odyssey. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[34]  F. Dati,et al.  Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage , 1999, Clinical chemistry and laboratory medicine.

[35]  M. Panteghini Biochemical assessment of myocardial damage with new diagnostic tools. , 1999, Cardiologia.

[36]  M Zaninotto,et al.  Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. , 1999, American journal of clinical pathology.

[37]  D. Fink,et al.  Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. , 1999, Clinical chemistry.

[38]  R. Jesse Myocardial necrosis in "pure unstable angina": identification of high-risk subgroups or a contradiction in terms? , 1999, American heart journal.

[39]  M. Panteghini,et al.  The Sensitivity of Cardiac Markers: an Evidence-based Approach , 1999, Clinical chemistry and laboratory medicine.

[40]  A. Wu,et al.  Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. , 1998, European heart journal.

[41]  M. Panteghini,et al.  Diagnostic application of CK-MB mass determination. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[42]  F. Apple,et al.  Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.

[43]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[44]  F. Harrell,et al.  Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .

[45]  M. Noble,et al.  Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. , 1996, Circulation.

[46]  L. Wallentin,et al.  Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. , 1996, Circulation.

[47]  E. Cook,et al.  Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). , 1989, The American journal of cardiology.

[48]  H E Solberg,et al.  Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[49]  C. Petitclerc,et al.  Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values , 1987 .

[50]  H. E. Solberg Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits , 1987 .

[51]  G W Rouan,et al.  Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. , 1987, The American journal of cardiology.

[52]  H E Solberg,et al.  The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[53]  A. Wu,et al.  Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[54]  R. Christenson,et al.  Evidence based approach to practice guides and decision thresholds for cardiac markers. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[55]  F. Apple Biochemical markers of thrombolytic success , 1999 .

[56]  K. Hallermayer,et al.  Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[57]  F. Apple,et al.  Clinical and analytical standardization issues confronting cardiac troponin I. , 1999, Clinical chemistry.

[58]  B. Lindahl Therapeutic implications of the use of cardiac markers in acute coronary syndromes. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[59]  F. Apple Biochemical markers of thrombolytic success. IFCC Committee on Standardization of Markers of Cardiac Damage. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.